COVID-19 drug Paxlovid’s price likely to be based on Japan
By Lee, Tak-Sun | translator Kang, Shin-Kook
24.09.06 05:43:11
가나다라
0
Reimbursement listing process is underway for its reimbursement in October
Expected to cost around KRW 900,000...application of a lower co-insurance rate is key

The insurance ceiling price of Pfizer's COVID-19 drug Paxlovid is likely to be set at around KRW 900,000 in Korea.
This is similar to its price in Japan. Japan is said to have the lowest price for Paxlovid among the A8 countries.
According to industry sources on the 4th, Paxlovid passed the Drug Reimbursement Evaluation Committee (DREC) on the 29th of last month after undergoing economic evaluation. The drug will be registered for health insurance reimbursement benefits after the company negotiates the drug price with the National Health Insurance Service.
The key is its price. DREC reportedly deliberated on a price in the KRW 1 million range and approved the drug’s reim
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)